After two years of dedication, INTERFARMA published a study in defense of a National Policy for Rare Diseases in Brazil.
Para baixar o PDF, Click aqui.
After two years of dedication, INTERFARMA published a study in defense of a National Policy for Rare Diseases in Brazil.
Para baixar o PDF, Click aqui.